RS Neuro Suite available on SYLVER Ultrasound Cart
To help healthcare professionals monitor patients with brain disorders, RS Neuro Suite offers new transcranial ultrasound imaging modes to bring better information to the standard of care.
The B-Mode is designed to provide high-resolution grayscale images, offering clear visualization of tissue structures. This essential mode allows for standard anatomical assessments, ensuring reliable results for routine diagnostics.
The Contrast-Enhanced Doppler combines color-coded blood flow imaging with the increased sensitivity of contrast agents. This mode enhances evaluation of flow velocity in large arteries.
The Microvascular Imaging Mode enhances the visualization of blood flow in small vessels using contrast agents. This mode enables clinicians to obtain a detailed view of microvascular structures.
Perfusion Mode tracks the Time to Peak intensity following the bolus injection of contrast agents, providing real-time insights into tissue perfusion. This mode helps assessing blood flow dynamics and tissue viability.
RS Neuro Suite is integrated into SYLVER, designed to support the next generation of ultrasound software.
SYLVER is built with flexibility at its core. Its software-based platform ensures that as technology advances, SYLVER evolves alongside it. New features and updates can be easily integrated, keeping healthcare professionals at the forefront of care—without the need for hardware changes.
SYLVER offers the portability of a conventional ultrasound system combined with powerful imaging capabilities. Lightweight and easy to maneuver, it can be effortlessly positioned at the patient’s bedside. With just one probe and a single scan, SYLVER brings a comprehensive set of images in under two minutes—ideal for frequent monitoring.
SYLVER is designed for use by clinicians without extensive expertise in ultrasonography. The RS Neuro Suite’s minimalist interface and dynamic visualization simplify both data acquisition and interpretation, making SYLVER a practical solution for everyday use, particularly in tracking a patient’s progress over time.
The delayed ischemic risk score predicts the likelihood of delayed brain damage following severe neurological injury. In intensive care units, this will help doctors to adapt their therapeutic strategy in patients with a high-risk profile.
The arterial permeability index aims to offer a crucial method to evaluate blood supply to the brain. It assesses whether there are any blockages in the major blood vessels supplying the brain. This aims to assist doctors in determining whether a patient requires specialized treatment to clear any blocked blood vessels.
RS Neuro Suite is an advanced ultrasound software engine designed to expand access to diagnostics, address unmet medical needs, and support the precision treatments of the future.
SYLVER is the first ultrasound platform integrating RS Neuro Suite.
RS Neuro Suite, RS General Imaging Suite, RS USP, RS LVO, and SYLVER are registered trademarks of Resolve Stroke. These products are currently in the research and development phase and will be available for sale upon receiving regulatory clearance.
Exclusively for clinical investigation, no regulatory approvals
